The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 21, 2017
Filed:
Sep. 14, 2012
Applicants:
Uwe Michaelis, Weilheim, DE;
Erika Jensen-jarolim, Vienna, AT;
Christoph Rehfuess, München, DE;
Margit Weghofer, Vienna, AT;
Inventors:
Uwe Michaelis, Weilheim, DE;
Erika Jensen-Jarolim, Vienna, AT;
Christoph Rehfuess, München, DE;
Margit Weghofer, Vienna, AT;
Assignee:
Medigene AG, Planegg-Martinsried, DE;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/23 (2006.01); A61K 39/385 (2006.01); C12N 7/00 (2006.01); C12P 21/00 (2006.01); C07K 14/71 (2006.01); C07K 14/435 (2006.01); C07K 14/015 (2006.01); A61K 39/00 (2006.01); C07K 14/005 (2006.01); A61K 39/39 (2006.01);
U.S. Cl.
CPC ...
A61K 39/0011 (2013.01); A61K 39/39 (2013.01); C07K 14/005 (2013.01); C07K 14/71 (2013.01); C12N 7/00 (2013.01); C12P 21/00 (2013.01); A61K 2039/5258 (2013.01); A61K 2039/54 (2013.01); A61K 2039/543 (2013.01); A61K 2039/545 (2013.01); A61K 2039/55505 (2013.01); A61K 2039/55561 (2013.01); A61K 2039/55572 (2013.01); A61K 2039/575 (2013.01); A61K 2039/6075 (2013.01); A61K 2039/645 (2013.01); C07K 2319/00 (2013.01); C07K 2319/735 (2013.01); C12N 2750/14022 (2013.01); C12N 2750/14023 (2013.01); C12N 2750/14122 (2013.01); C12N 2750/14123 (2013.01); Y10T 428/2984 (2015.01);
Abstract
The present invention relates to parvovirus mutated structural proteins comprising insertions of mimotopes of a HER2, compositions, multimeric structures, medicaments and vaccines comprising the same, nucleic acids, expression cassettes, constructs, vectors and cells comprising the nucleic acids, methods of preparing the structural proteins and methods of inducing a B-cell response or of treating a HER2-related disease.